Table 2.

Descriptive statistics of the SMs in DTC survivors by their treatment

	Number of patients, n(%)		Number of Females, n(%)		Proportion of patients by race(W/B/API)		Proportion of patients by disease stage (Local/Regional/Distant)		Median age at diagnosis of the SMs, yrs		Median follow-up time since the diagnosis of SMs,months		Median latency time, months
	+RAI	-RAI	+RAI	-RAI	+RAI	-RAI	+RAI	-RAI	+RAI	-RAI	+RAI	-RAI	+RAI	-RAI
All cancer combined	2289	2339	68.7%	72.6%	83%/5%/11%	85%/8% /0%	50%/18% /17%	50%/21% /16%	62	64	28	26	70	70
Oral Cavity and Pharynx	56	51	64.3%	64.7%	79%/5% /16%	78%/12%/10%	48%/11% /7%	39%/12% /8%	58	59	22	24	68	73
Digestive System	319	356	69.0%	72.5%	78%/8% /14%	81%/10%/10%	36%/28% /24%	34%/32% /4%	64	65	19	14	73	68
Respiratory System	247	254	68.8%	72.4%	82%/5% /12%	83%/9% /8%	24%/17% /52%	24%/24% /48%	68	66	14	10	68	66
Skin	138	137	63.0%	67.2%	96%/1% /4%	96%/1% /2%	76%/9% /3%	78%/11% /1%	56	64	35	31	65	68
Breast	547	574	99.5%	99.8%	80%/5% /15%	82%/10%/8%	65%/30% /4%	66%/30% /3%	58	61	35	34	73	74
Female Genital System	179	206	100.0%	100.0%	83%/7% /10%	82%/5% /12%	61%/16% /16%	51%/23% /21%	60	62	29	26	66	67
Male Genital System	237	233	0.0%	0.0%	84%/7% /9%	88%/9% /3%	79%/14% /3%	82%/12% /2%	65	66	38	50	70	69
Urinary System	194	191	43.3%	57.6%	89%/3% /8%	90%/5% /6%	55%/12% /10%	56%/9% /8%	64	67	30	31	71	78
Nervous System	30	36	80.0%	69.4%	87%/7% /7%	94%/3% /0%	73%/20% /3%	86%/8% /0%	57	60	15	12	55	60
Hematologic System	261	215	65.1%	65.6%	84%/4% /11%	87%/7% /4%	NA	NA	63	66	27	23	65	73